Cogstate Ownership
| COGZF Stock | USD 0.89 0.06 7.23% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cogstate |
Cogstate OTC Stock Ownership Analysis
About 43.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 216.67. Cogstate Limited had not issued any dividends in recent years. The entity had 110:109 split on the 22nd of October 2019. Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia. Cogstate operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 380 people.The quote for Cogstate Limited is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Cogstate Limited please contact BBus CA at 61 3 9664 1300 or go to https://www.cogstate.com.Currently Active Assets on Macroaxis
Other Information on Investing in Cogstate OTC Stock
Cogstate financial ratios help investors to determine whether Cogstate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cogstate with respect to the benefits of owning Cogstate security.